SB
PDSB icon

Samsara BioCapital’s PDS Biotechnology PDSB Stock Holding History

Samsara BioCapital’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,166
Closed -$55K – 19
2019
Q2 		$55K Hold
9,166
– – 0.04% 20
2019
Q1 		$68K Sell
9,166
-1
-0% -$8 0.05% 17
2018
Q4 		$59K Buy
+9,167
New +$121K 0.06% 17

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
RC
RegentAtlantic Capital Morristown, New Jersey $3.34B AUM 14.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IGGA
Iron Gate Global Advisors Nsl, Utah $947M AUM 23.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Samsara BioCapital's PDSB Position: Q3 2019 in Review

Samsara BioCapital sold out of PDS Biotechnology (PDSB) in Q3 2019, closing a stake of 9,166 shares — an estimated $55K sold.

Samsara BioCapital first reported a position in PDSB in Q4 2018 and held it in 3 quarters. The position peaked at $68K in Q1 2019. 21 funds tracked by Wall St. Rank hold PDSB as of Q3 2019.

  • Samsara BioCapital reported no remaining PDS Biotechnology position as of Q3 2019 after selling out during the quarter.
  • Samsara BioCapital sold 9,166 PDS Biotechnology shares in Q3 2019, an estimated $55K.
  • Samsara BioCapital first reported a position in PDS Biotechnology in Q4 2018 and held it in 3 quarters.
  • Samsara BioCapital's PDS Biotechnology position peaked at $68K in Q1 2019.
  • 21 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2019.

Based on Samsara BioCapital's 13F filing for Q3 2019, filed 14 Nov 2019.